Sjoerd D. Joustra

Dr. Sjoerd D. Joustra


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
SJSjoerd D. Joustra
Sjoerd D. Joustra
NSN. Schoenmakers
N. Schoenmakers
LPLuca Persani
Luca Persani
ICIrene Campi
Irene Campi
MBMarco Bonomi
Marco Bonomi
ATA. S. P. van Trotsenburg
A. S. P. van Trotsenburg
Context: Ig superfamily member 1 (IGSF1) deficiency was recently discovered as a novel X-linked cause of central hypothyroidism (CeH) and macro-orchidism. However, clinical and biochemical data regarding growth, puberty, and metabolic outcome, as well as features of female carriers, are scarce. Objective: Our objective was to investigate clinical and biochemical characteristics associated with IGSF1 deficiency in both sexes. Methods: All patients (n = 42, 24 males) from 10 families examined in the university clinics of Leiden, Amsterdam, Cambridge, and Milan were included in this case series. Detailed clinical data were collected with an identical protocol, and biochemical measurements were performed in a central laboratory. Results: Male patients (age 0–87 years, 17 index cases and 7 from family studies) showed CeH (100%), hypoprolactinemia (n = 16, 67%), and transient partial GH deficiency (n = 3, 13%). Pubertal testosterone production was delayed, as were the growth spurt and pubic hair development. However, testicular growth started at a normal age and attained macro-orchid size in all evaluable adults. Body mass index, percent fat, and waist circumference tended to be elevated. The metabolic syndrome was present in 4 of 5 patients over 55 years of age. Heterozygous female carriers (age 32–80 years) showed CeH in 6 of 18 cases (33%), hypoprolactinemia in 2 (11%), and GH deficiency in none. As in men, body mass index, percent fat, and waist circumference were relatively high, and the metabolic syndrome was present in 3 cases. Conclusion: In male patients, the X-linked IGSF1 deficiency syndrome is characterized by CeH, hypoprolactinemia, delayed puberty, macro-orchidism, and increased body weight. A subset of female carriers also exhibits CeH.

9 February 2015 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
SJSjoerd D. Joustra
Sjoerd D. Joustra
EPEvelyn M. van der Plas
Evelyn M. van der Plas
JGJoery Goede
Joery Goede
WOWilma Oostdijk
Wilma Oostdijk
HWHenriette A. Delemarre‐Van de Waal
Henriette A. Delemarre‐Van de Waal
JWJan M. Wit
Jan M. Wit

1 August 2014 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
SJSjoerd D. Joustra
Sjoerd D. Joustra
RTRoland Thijs
Roland Thijs
RBR van Den Berg
R van Den Berg
MDM van Dijk
M van Dijk
APA.M. Pereira
A.M. Pereira
NBN R Biermasz
N R Biermasz
Objective: Patients treated for nonfunctioning pituitary macroadenomas (NFMAs) have fatigue and alterations in sleep characteristics and sleep–wake rhythmicity frequently. As NFMAs often compress the optic chiasm, these complaints might be related to dysfunction of the adjacent suprachiasmatic nucleus (SCN). We aimed to explore whether indirect indices of SCN functioning are altered in the long term after surgery for NFMAs.Methods: We studied 17 NFMA patients in long-term remission after transsphenoidal surgery, receiving adequate and stable hormone replacement for hypopituitarism, and 17 control subjects matched for age, gender, and BMI. Indirect indices of SCN function were assessed from 24-h ambulatory recordings of skin and core body temperatures, blood pressure, and salivary melatonin levels. Altered melatonin secretion was defined as an absence of evening rise, considerable irregularity, or daytime values >3 pg/ml. We additionally studied eight patients treated for craniopharyngioma.Results: Distal–proximal skin temperature gradient did not differ between NFMAs and control subjects, but proximal skin temperature was decreased during daytime (P=0.006). Core body temperature and non-dipping of blood pressure did not differ, whereas melatonin secretion was often altered in NFMAs (OR 5.3, 95% CI 0.9–30.6). One or more abnormal parameters (≥2.0 SDS of control subjects) were observed during nighttime in 12 NFMA patients and during daytime in seven NFMA patients. Similar patterns were observed in craniopharyngioma patients.Conclusion: Heterogeneous patterns of altered diurnal rhythmicity in skin temperature and melatonin secretion parameters were observed in the majority of patients treated for NFMAs. On a group level, both NFMA and craniopharyngioma patients showed a lower daytime proximal skin temperature than control subjects, but other group averages were not significantly different. The observations suggest altered function of central (or peripheral) clock machinery, possibly by disturbed entrainment or damage of the hypothalamic SCN by the suprasellar macroadenoma or its treatment.

1 January 2013 in Rare Diseases
Verified
Journal Article
Open access
SJSjoerd D. Joustra
Sjoerd D. Joustra
ATA. S. Paul van Trotsenburg
A. S. Paul van Trotsenburg
YSYu Sun
Yu Sun
MLMonique Losekoot
Monique Losekoot
DBDaniel J. Bernard
Daniel J. Bernard
JWJan M. Wit
Jan M. Wit
A recently uncovered X-linked syndrome, caused by loss-of-function of IGSF1, is characterized by congenital central hypothyroidism and macroorchidism, variable prolactin deficiency, occasional growth hormone deficiency, delayed pubertal testosterone secretion and obesity. We propose to call this endocrinopathy “IGSF1 deficiency syndrome.” Based on an estimated incidence of isolated congenital central hypothyroidism of 1:65,000, we predict that the incidence of IGSF1 deficiency related hypothyroidism is approximately 1:100,000. IGSF1 encodes a plasma membrane immunoglobulin superfamily glycoprotein that is highly expressed in pituitary and testis, but is of unknown function. The variable profile of pituitary dysfunction suggests that IGSF1 may play a role in pituitary paracrine regulation. The clinical significance of the syndrome, particularly the clinical consequences of untreated hypothyroidism, justifies screening family members of patients with IGSF1 mutations for carriership and to study potential ca...

10 July 2015 in Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
SJSjoerd D. Joustra
Sjoerd D. Joustra
Onno C. MeijerOnno C. Meijer
Onno C. Meijer
CHCharlotte A Heinen
Charlotte A Heinen
IMIsabel M Mol
Isabel M Mol
ELEl Houari Laghmani
El Houari Laghmani
GWGerry T M Wagenaar
Gerry T M Wagenaar
Loss-of-function mutations in the immunoglobulin superfamily member 1 (IGSF1) gene cause an X-linked syndrome of central hypothyroidism, macroorchidism, variable prolactin and GH deficiency, delayed pubertal testosterone rise, and obesity. To understand the pathophysiology of this syndrome, knowledge on IGSF1's place in normal development is imperative. Therefore, we investigated spatial and temporal protein and mRNA expression of IGSF1 in rats using immunohistochemistry, real-time quantitative PCR (qPCR), andin situhybridization. We observed high levels of IGSF1 expression in the brain, specifically the embryonic and adult choroid plexus and hypothalamus (principally in glial cells), and in the pituitary gland (PIT1-lineage of GH, TSH, and PRL-producing cells). IGSF1 is also expressed in the embryonic and adult zona glomerulosa of the adrenal gland, islets of Langerhans of the pancreas, and costameres of the heart and skeletal muscle. IGSF1 is highly expressed in fetal liver, but is absent shortly after birth. In the adult testis, IGSF1 is present in Sertoli cells (epithelial stages XIII–VI), and elongating spermatids (stages X–XII). Specificity of protein expression was corroborated withIgsf1mRNA expression in all tissues. The expression patterns of IGSF1 in the pituitary gland and testis are consistent with the pituitary hormone deficiencies and macroorchidism observed in patients with IGSF1 deficiency. The expression in the brain, adrenal gland, pancreas, liver, and muscle suggest IGSF1's function in endocrine physiology might be more extensive than previously considered.

30 October 2014 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SJSjoerd D. Joustra
Sjoerd D. Joustra
KWKaroliina Wehkalampi
Karoliina Wehkalampi
WOWilma Oostdijk
Wilma Oostdijk
NBNienke R. Biermasz
Nienke R. Biermasz
SHSasha Howard
Sasha Howard
MLMonique Losekoot
Monique Losekoot